Actively Recruiting

Age: 18Years +
All Genders
NCT03253536

Prospective Observational Trial to Evaluate Quality of Life After Stereotactic Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma

Led by Ludwig-Maximilians - University of Munich · Updated on 2017-08-18

100

Participants Needed

1

Research Sites

521 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Prospective single arm, single center observational study to evaluate Quality of Life (Qol) after stereotactic body radiotherapy for patients with hepatocellular cancer. Patients will receive work-up, treatment and follow-up exclusively as routinely done except additional quality of life measurements. Qol will be measured by standardized and validated EORTC questionaires at different time points during routine follow-up.

CONDITIONS

Official Title

Prospective Observational Trial to Evaluate Quality of Life After Stereotactic Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Histologically or radiologically confirmed hepatocellular carcinoma
  • Presence of 1 to 3 lesions suitable for stereotactic radiation therapy
  • Indication for stereotactic body radiotherapy as determined by a multidisciplinary board
  • Age 18 years or older
  • Provided written informed consent for study participation
  • Mental and verbal ability to complete standardized questionnaires as assessed by the investigator
Not Eligible

You will not qualify if you...

  • Younger than 18 years old
  • Prior systemic therapy specific to hepatocellular carcinoma
  • Receiving concurrent oncological systemic treatment
  • Presence of distant metastases
  • Inability to comply with the study protocol or complete standardized questionnaires
  • Unable to undergo contrast-enhanced planning CT
  • Unable to provide informed consent
  • Under legal custody

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Department of Radiation Oncology, University Hospital, LMU Munich

Munich, Bavaria, Germany, 81377

Actively Recruiting

Loading map...

Research Team

F

Falk Roeder, MD

CONTACT

S

Sabine Gerum, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here